ARCHIVES

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

This article is from The Cancer Letter archive.

Vol. 24 No. 45 | November 27, 1998

Download PDF Visit The Full Archive

Related Articles

NCI to Implement More Transparent Formula For Calculating Cancer Center Support Grants

June 11, 2014

CPRIT Awards $107.2 Million Round of Grants

September 5, 2014

TJU Wins NCI Renewal Of Kimmel Center Core Grant; 11 NY Centers Testing Spiral CT.

July 13, 2001

In Brief: Online Genetics Glossary; ORI Misconduct Finding

February 5, 1999

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

Ohio State Schedules Workshop On CCOP

February 5, 1982